Skip to the content
  • Suomeksi
  • About Us
    • > Our role
    • > BoD and management
    • > Sustainability
  • Pharma Sector
    • > Feasibilities and inquiries
    • > Research archive
    • > References for post-licensure studies
  • Newsfeed
  • Contacts
  • Suomeksi

Tag: RS-virus

  • In category NewsPosted on 31.03.2023

    Why partner with FVR – Finnish Vaccine Research in studying vaccines for RSV?

    FVR’s unique network of ten clinical vaccine research clinics ensures good capacity and flexibility is available for conducting a successful study. ​Our expertise covers comprehensive clinical vaccine trials through phases 1-4, including register-based Real-World Evidence studies and large-scale pragmatic field trials, conducted together with healthcare providers​. Finland offers an excellent setting for a successful study […]

  • About Us
    • Our role
    • BoD and management
    • Sustainability
  • Pharma Sector
    • Feasibilities and inquiries
    • Research archive
    • References for post-licensure studies
  • Newsfeed
  • Contacts

FVR - Finnish Vaccine Research
Peltokatu 26, 33100 Tampere, Finland
info@fvr.fi Business ID FI32566594

  • About cookies

© Copyrights 2022 FVR – Finnish Vaccine Research